Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated July 14, 2011, covers events occurring on July 13, 2011. Lexaria Corp. (Lexaria Bioscience Corp.) reported unregistered sales of equity securities, including warrant conversions and a private placement of units.
Key Financial Metrics
- Total Gross Proceeds: $104,609 (US$34,609 from warrant conversions + $70,000 from private placement).
- Warrant Conversion: 173,043 warrants converted at $0.20 per warrant into 173,043 common shares.
- Private Placement: 200,000 units sold at $0.35 per unit.
- Unit Composition: One common share and one non-transferable warrant per unit.
- Warrant Terms: Exercise price of $0.50 per share; expiration date of July 14, 2013.
- Transaction Costs: $3,500 in commissions paid to Tom Ihrke.
Material Changes
The filing details a significant increase in share count and cash liquidity through the issuance of 373,043 new common shares (173,043 from conversions and 200,000 from the private placement). The filing does not provide comparative financial data for prior periods as it is a current report on specific capital events rather than a periodic financial statement.
Outlook, Risks, and Use of Proceeds
- Use of Proceeds: Funds are designated for operations at the Company's Belmont Lake Oil Field and for general working capital.
- Regulatory Compliance: Securities were issued pursuant to Rule 506 of Regulation D (to accredited investors) and Regulation S (to non-US persons). The securities are unregistered and cannot be resold in the US without registration or an exemption.
- Management Commentary: No specific forward-looking guidance or risk factors beyond standard regulatory disclosures were included in this specific filing text.
Investor Verification Checklist
- Verify the total number of outstanding shares post-transaction to assess dilution impact.
- Confirm the current status and operational progress of the Belmont Lake Oil Field.
- Review the full press release (Exhibit 99.1) for additional context on the private placement.
- Check subsequent filings for the utilization of the $104,609 in proceeds.